Search research articles
Contact Us
Filters
Showing results (631-640 of 692) with videos related to
Page
of 70
Sort By:
Nature Communications
|
May 28, 2025
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study
Mitchell Emmers, Marij J P Welters, Michelle V Dietz, et al.
Frontiers in Immunology
|
September 11, 2024
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy
Anastasia Gangaev, Yannick van Sleen, Nicole Brandhorst, et al.
Trials
|
June 10, 2024
Investigating non-inferiority of internet-delivered versus face-to-face cognitive behavioural therapy for insomnia (CBT-I): a randomised controlled trial (iSleep well)
F Benz, L Grolig, S Hannibal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2019
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S Trebeschi, S G Drago, N J Birkbak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 23, 2015
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort
Oliver Gautschi, Julie Milia, Bastien Cabarrou, et al.
British Journal of Cancer
|
February 27, 2015
DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach
A J Hubers, D A M Heideman, S A Burgers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2015
Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort
Julien Mazières, Gérard Zalcman, Lucio Crinò, et al.
The New England Journal of Medicine
|
April 15, 2026
First-Line Zongertinib in Advanced <i>HER2</i>-Mutant Non-Small-Cell Lung Cancer
John V Heymach, Noboru Yamamoto, Nicolas Girard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2017
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong-Wan Kim, Marcello Tiseo, Myung-Ju Ahn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 28, 2003
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
Paul Verboom, Harm van Tinteren, Otto S Hoekstra, et al.
Page
of 70
Search research articles
Search
Showing results (631-640 of 692) with videos related to
Sort By:
Page
of 70
Nature Communications
|
May 28, 2025
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study
Mitchell Emmers, Marij J P Welters, Michelle V Dietz, et al.
Frontiers in Immunology
|
September 11, 2024
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy
Anastasia Gangaev, Yannick van Sleen, Nicole Brandhorst, et al.
Trials
|
June 10, 2024
Investigating non-inferiority of internet-delivered versus face-to-face cognitive behavioural therapy for insomnia (CBT-I): a randomised controlled trial (iSleep well)
F Benz, L Grolig, S Hannibal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2019
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S Trebeschi, S G Drago, N J Birkbak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 23, 2015
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort
Oliver Gautschi, Julie Milia, Bastien Cabarrou, et al.
British Journal of Cancer
|
February 27, 2015
DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach
A J Hubers, D A M Heideman, S A Burgers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2015
Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort
Julien Mazières, Gérard Zalcman, Lucio Crinò, et al.
The New England Journal of Medicine
|
April 15, 2026
First-Line Zongertinib in Advanced <i>HER2</i>-Mutant Non-Small-Cell Lung Cancer
John V Heymach, Noboru Yamamoto, Nicolas Girard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2017
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong-Wan Kim, Marcello Tiseo, Myung-Ju Ahn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 28, 2003
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
Paul Verboom, Harm van Tinteren, Otto S Hoekstra, et al.
Page
of 70